Remote Monitoring Solution Detects COPD Exacerbations Three Days Early
French medical device company Biosency unveiled its latest clinical results demonstrating the ability of its BVS3 technology to predict acute chronic obstructive pulmonary disease exacerbations, on average, three days prior to hospitalization in 86% of cases.